2023 Was a tricky year for your biopharma sector, with numerous companies downsizing and restructuring their workforces to stay afloat. You will find indications of Restoration, as mergers and acquisitions picked up across the pharmaceutical and everyday living sciences industry in the latter A part of 2023 and have ongoing https://sites.google.com/view/bio-sites/blog